James Rusch, MD
Psychiatry · Gulfport, MSNPI 1780618686
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Teva Pharmaceuticals USA, Inc. accounts for 61.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $2,011 and has fallen 93.2% since, to $137 in 2025.
Across 28 payments — averaging $111.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- AbbVie$602
- Neurocrine Biosciences, Inc.$153
- Alkermes, Inc.$138
- Johnson & Johnson$114
- Vanda Pharmaceuticals Inc.$59
- plus $123 from 4 others
What the payments were for
- Speaking & faculty fees$1,58651%
- Travel & lodging$201%
- Food & beverage$1,51649%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $1,932 |
| AbbVie(2 entities) | 6 | $602 |
| Neurocrine Biosciences, Inc. | 2 | $153 |
| Alkermes, Inc. | 3 | $138 |
| Johnson & Johnson | 3 | $114 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Indivior Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,122 in reported general payments places this provider in the 80th percentile of 219 psychiatry providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PerserisRisperidone | 11 | $30,780 |
| Mirtazapine | 14 | $262 |
| Olanzapine | 20 | $209 |
| Benztropine Mesylate | 13 | $84 |
| Trazodone Hcl | 14 | $51 |
| Buspirone Hcl | 11 | $47 |
| Fluoxetine Hcl | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Perseris | $24 | $30,78011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 219 psychiatry providers in Mississippi.
Other psychiatry in Gulfport
- Maxie GordonClinton$1.3M
- Kurt BuechlerRidgeland$1.1M
- Chasity TorrenceWhitfield$834K
- Jon JacksonJackson$834K
- John NortonJackson$173K
- Amy MillerSaltillo$82K
- Clyde GlennRidgeland$68K
- Krishan GuptaJackson$26K
- Joseph KwentusFlowood$13K
- Mark WebbRidgeland$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.